Mechanistic insights and potential therapeutic approaches for NUP98-rearranged hematologic malignancies

Harrison, 2010, Cytogenetics of childhood acute myeloid leukemia: United Kingdom Medical Research Council Treatment trials AML 10 and 12, J Clin Oncol, 28, 2674, 10.1200/JCO.2009.24.8997 Kim, 2020, Cryptic genomic lesions in adverse-risk acute myeloid leukemia identified by integrated whole genome and transcriptome sequencing, Leukemia, 34, 306, 10.1038/s41375-019-0546-1 Iacobucci, 2019, Genomic subtyping and therapeutic targeting of acute erythroleukemia, Nat Genet, 51, 694, 10.1038/s41588-019-0375-1 Bolouri, 2018, The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions [published corrections appear in Nat Med. 2018;24(4):526 and Nat Med. 2019;25(3):530], Nat Med, 24, 103, 10.1038/nm.4439 Gu, 2016, Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia, Nat Commun, 7, 13331, 10.1038/ncomms13331 Roberts, 2015, Genomics in acute lymphoblastic leukaemia: insights and treatment implications, Nat Rev Clin Oncol, 12, 344, 10.1038/nrclinonc.2015.38 Druker, 2001, Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome, N Engl J Med, 344, 1038, 10.1056/NEJM200104053441402 Druker, 2001, Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia, N Engl J Med, 344, 1031, 10.1056/NEJM200104053441401 Krull, 2004, Nucleoporins as components of the nuclear pore complex core structure and Tpr as the architectural element of the nuclear basket, Mol Biol Cell, 15, 4261, 10.1091/mbc.e04-03-0165 Chatel, 2012, Domain topology of nucleoporin Nup98 within the nuclear pore complex, J Struct Biol, 177, 81, 10.1016/j.jsb.2011.11.004 Rosenblum, 1999, Autoproteolysis in nucleoporin biogenesis, Proc Natl Acad Sci USA, 96, 11370, 10.1073/pnas.96.20.11370 Capelson, 2010, Chromatin-bound nuclear pore components regulate gene expression in higher eukaryotes, Cell, 140, 372, 10.1016/j.cell.2009.12.054 Laurell, 2011, Phosphorylation of Nup98 by multiple kinases is crucial for NPC disassembly during mitotic entry, Cell, 144, 539, 10.1016/j.cell.2011.01.012 Kalverda, 2010, Nucleoporins directly stimulate expression of developmental and cell-cycle genes inside the nucleoplasm, Cell, 140, 360, 10.1016/j.cell.2010.01.011 Radu, 1995, The peptide repeat domain of nucleoporin Nup98 functions as a docking site in transport across the nuclear pore complex, Cell, 81, 215, 10.1016/0092-8674(95)90331-3 Griffis, 2002, Nup98 is a mobile nucleoporin with transcription-dependent dynamics, Mol Biol Cell, 13, 1282, 10.1091/mbc.01-11-0538 Oka, 2010, The mobile FG nucleoporin Nup98 is a cofactor for Crm1-dependent protein export, Mol Biol Cell, 21, 1885, 10.1091/mbc.e09-12-1041 Blevins, 2003, Complex formation among the RNA export proteins Nup98, Rae1/Gle2, and TAP, J Biol Chem, 278, 20979, 10.1074/jbc.M302061200 Pritchard, 1999, RAE1 is a shuttling mRNA export factor that binds to a GLEBS-like NUP98 motif at the nuclear pore complex through multiple domains, J Cell Biol, 145, 237, 10.1083/jcb.145.2.237 Nakamura, 1996, Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia, Nat Genet, 12, 154, 10.1038/ng0296-154 Borrow, 1996, The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9, Nat Genet, 12, 159, 10.1038/ng0296-159 Arai, 1997, The inv(11)(p15q22) chromosome translocation of de novo and therapy-related myeloid malignancies results in fusion of the nucleoporin gene, NUP98, with the putative RNA helicase gene, DDX10, Blood, 89, 3936, 10.1182/blood.V89.11.3936 Nishiyama, 1999, 11p15 translocations involving the NUP98 gene in childhood therapy-related acute myeloid leukemia/myelodysplastic syndrome, Genes Chromosomes Cancer, 26, 215, 10.1002/(SICI)1098-2264(199911)26:3<215::AID-GCC5>3.0.CO;2-1 Fujino, 2002, Single-translocation and double-chimeric transcripts: detection of NUP98-HOXA9 in myeloid leukemias with HOXA11 or HOXA13 breaks of the chromosomal translocation t(7;11)(p15;p15), Blood, 99, 1428, 10.1182/blood.V99.4.1428 Yamamoto, 2000, Expression of the NUP98/HOXA9 fusion transcript in the blast crisis of Philadelphia chromosome-positive chronic myelogenous leukaemia with t(7;11)(p15;p15), Br J Haematol, 109, 423, 10.1046/j.1365-2141.2000.02003.x Hussey, 1999, The (4;11)(q21;p15) translocation fuses the NUP98 and RAP1GDS1 genes and is recurrent in T-cell acute lymphocytic leukemia, Blood, 94, 2072, 10.1182/blood.V94.6.2072 Panagopoulos, 2007, Fusion of NUP98 and the SET binding protein 1 (SETBP1) gene in a paediatric acute T cell lymphoblastic leukaemia with t(11;18)(p15;q12), Br J Haematol, 136, 294, 10.1111/j.1365-2141.2006.06410.x Romana, 2006, NUP98 rearrangements in hematopoietic malignancies: a study of the Groupe Francophone de Cytogénétique Hématologique, Leukemia, 20, 696, 10.1038/sj.leu.2404130 Pan, 2008, A new fusion gene NUP98-IQCG identified in an acute T-lymphoid/myeloid leukemia with a t(3;11)(q29q13;p15)del(3)(q29) translocation, Oncogene, 27, 3414, 10.1038/sj.onc.1210999 Ma, 2018, Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours, Nature, 555, 371, 10.1038/nature25795 Struski, 2017, NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis, Leukemia, 31, 565, 10.1038/leu.2016.267 Niktoreh, 2019, Mutated WT1, FLT3-ITD, and NUP98-NSD1 fusion in various combinations define a poor prognostic group in pediatric acute myeloid leukemia, J Oncol, 2019, 1609128, 10.1155/2019/1609128 Bisio, 2017, NUP98-fusion transcripts characterize different biological entities within acute myeloid leukemia: a report from the AIEOP-AML group, Leukemia, 31, 974, 10.1038/leu.2016.361 Hollink, 2011, NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern, Blood, 118, 3645, 10.1182/blood-2011-04-346643 Taketani, 2002, Novel NUP98-HOXC11 fusion gene resulted from a chromosomal break within exon 1 of HOXC11 in acute myeloid leukemia with t(11;12)(p15;q13), Cancer Res, 62, 4571 La Starza, 2003, Human homeobox gene HOXC13 is the partner of NUP98 in adult acute myeloid leukemia with t(11;12)(p15;q13), Genes Chromosomes Cancer, 36, 420, 10.1002/gcc.10182 Taketani, 2002, The HOXD11 gene is fused to the NUP98 gene in acute myeloid leukemia with t(2;11)(q31;p15), Cancer Res, 62, 33 Raza-Egilmez, 1998, NUP98-HOXD13 gene fusion in therapy-related acute myelogenous leukemia, Cancer Res, 58, 4269 Jankovic, 2008, Leukemogenic mechanisms and targets of a NUP98/HHEX fusion in acute myeloid leukemia, Blood, 111, 5672, 10.1182/blood-2007-09-108175 Soler, 2013, Identification of GSX2 and AF10 as NUP98 partner genes in myeloid malignancies [letter], Blood Cancer J, 3, e124, 10.1038/bcj.2013.20 Nakamura, 1999, NUP98 is fused to PMX1 homeobox gene in human acute myelogenous leukemia with chromosome translocation t(1;11)(q23;p15), Blood, 94, 741, 10.1182/blood.V94.2.741 Gervais, 2005, A new translocation t(9;11)(q34;p15) fuses NUP98 to a novel homeobox partner gene, PRRX2, in a therapy-related acute myeloid leukemia, Leukemia, 19, 145, 10.1038/sj.leu.2403565 Lisboa, 2013, POU1F1 is a novel fusion partner of NUP98 in acute myeloid leukemia with t(3;11)(p11;p15), Mol Cancer, 12, 5, 10.1186/1476-4598-12-5 Hussey, 2002, Recurrent coiled-coil motifs in NUP98 fusion partners provide a clue to leukemogenesis, Blood, 99, 1097, 10.1182/blood.V99.3.1097 Roussy, 2018, NUP98-BPTF gene fusion identified in primary refractory acute megakaryoblastic leukemia of infancy, Genes Chromosomes Cancer, 57, 311, 10.1002/gcc.22532 Schwartz, 2017, The genomic landscape of pediatric myelodysplastic syndromes, Nat Commun, 8, 1557, 10.1038/s41467-017-01590-5 van Zutven, 2006, Identification of NUP98 abnormalities in acute leukemia: JARID1A (12p13) as a new partner gene, Genes Chromosomes Cancer, 45, 437, 10.1002/gcc.20308 Jaju, 2001, A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood acute myeloid leukemia, Blood, 98, 1264, 10.1182/blood.V98.4.1264 Rosati, 2002, NUP98 is fused to the NSD3 gene in acute myeloid leukemia associated with t(8;11)(p11.2;p15), Blood, 99, 3857, 10.1182/blood.V99.10.3857 Reader, 2007, A novel NUP98-PHF23 fusion resulting from a cryptic translocation t(11;17)(p15;p13) in acute myeloid leukemia, Leukemia, 21, 842, 10.1038/sj.leu.2404579 Kaltenbach, 2010, NUP98-MLL fusion in human acute myeloblastic leukemia, Blood, 116, 2332, 10.1182/blood-2010-04-277806 Hayashi, 2019, NUP98-HBO1-fusion generates phenotypically and genetically relevant chronic myelomonocytic leukemia pathogenesis, Blood Adv, 3, 1047, 10.1182/bloodadvances.2018025007 Ahuja, 2000, t(9;11)(p22;p15) in acute myeloid leukemia results in a fusion between NUP98 and the gene encoding transcriptional coactivators p52 and p75-lens epithelium-derived growth factor (LEDGF), Cancer Res, 60, 6227 de Rooij, 2013, NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern, Leukemia, 27, 2280, 10.1038/leu.2013.87 Noort, The clinical and biological characteristics of NUP98-KDM5A in pediatric acute myeloid leukemia [published online ahead of print 7 May 2020], Haematologica Cimino, 2001, Molecular evaluation of the NUP98/RAP1GDS1 gene frequency in adults with T-acute lymphoblastic leukemia, Haematologica, 86, 436 Panarello, 2002, Cryptic translocation t(5;11)(q35;p15.5) with involvement of the NSD1 and NUP98 genes without 5q deletion in childhood acute myeloid leukemia, Genes Chromosomes Cancer, 35, 277, 10.1002/gcc.10119 Tosić, 2009, Acute myeloid leukemia with NUP98-HOXC13 fusion and FLT3 internal tandem duplication mutation: case report and literature review, Cancer Genet Cytogenet, 193, 98, 10.1016/j.cancergencyto.2009.03.007 Shiba, 2013, NUP98-NSD1 gene fusion and its related gene expression signature are strongly associated with a poor prognosis in pediatric acute myeloid leukemia, Genes Chromosomes Cancer, 52, 683 Marceau-Renaut, 2018, Molecular profiling defines distinct prognostic subgroups in childhood AML: a report from the French ELAM02 Study Group, HemaSphere, 2, e31, 10.1097/HS9.0000000000000031 Hara, 2020, Patients aged less than 3 years with acute myeloid leukaemia characterize a molecularly and clinically distinct subgroup, Br J Haematol, 188, 528, 10.1111/bjh.16203 de Rooij, 2017, Pediatric non-Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes, Nat Genet, 49, 451, 10.1038/ng.3772 de Rooij, 2016, Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study, Blood, 127, 3424, 10.1182/blood-2016-01-695551 Shimada, 2018, Risk-stratified therapy for children with FLT3-ITD-positive acute myeloid leukemia: results from the JPLSG AML-05 study, Int J Hematol, 107, 586, 10.1007/s12185-017-2395-x Wei, 2013, Clinical and laboratory studies of 17 patients with acute myeloid leukemia harboring t(7;11)(p15;p15) translocation, Leuk Res, 37, 1010, 10.1016/j.leukres.2013.05.020 Chou, 2009, Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: comparative analysis of 493 adult patients, Leukemia, 23, 1303, 10.1038/leu.2009.25 Fasan, 2013, A rare but specific subset of adult AML patients can be defined by the cytogenetically cryptic NUP98-NSD1 fusion gene, Leukemia, 27, 245, 10.1038/leu.2012.230 Thol, 2013, Analysis of NUP98/NSD1 translocations in adult AML and MDS patients, Leukemia, 27, 750, 10.1038/leu.2012.249 Miyamura, 2019, Clinical and biological features of paediatric acute myeloid leukaemia (AML) with primary induction failure in the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 study, Br J Haematol, 185, 284, 10.1111/bjh.15799 Ostronoff, 2014, NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report, Blood, 124, 2400, 10.1182/blood-2014-04-570929 McNeer, 2019, Genetic mechanisms of primary chemotherapy resistance in pediatric acute myeloid leukemia, Leukemia, 33, 1934, 10.1038/s41375-019-0402-3 Kroon, 2001, NUP98-HOXA9 expression in hemopoietic stem cells induces chronic and acute myeloid leukemias in mice, EMBO J, 20, 350, 10.1093/emboj/20.3.350 Pineault, 2003, Induction of acute myeloid leukemia in mice by the human leukemia-specific fusion gene NUP98-HOXD13 in concert with Meis1, Blood, 101, 4529, 10.1182/blood-2002-08-2484 Gurevich, 2004, NUP98-topoisomerase I acute myeloid leukemia-associated fusion gene has potent leukemogenic activities independent of an engineered catalytic site mutation, Blood, 104, 1127, 10.1182/blood-2003-10-3550 Pineault, 2004, Differential and common leukemogenic potentials of multiple NUP98-Hox fusion proteins alone or with Meis1, Mol Cell Biol, 24, 1907, 10.1128/MCB.24.5.1907-1917.2004 Wang, 2007, NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis, Nat Cell Biol, 9, 804, 10.1038/ncb1608 Wang, 2009, Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger, Nature, 459, 847, 10.1038/nature08036 Hirose, 2008, Leukemogenic properties of NUP98-PMX1 are linked to NUP98 and homeodomain sequence functions but not to binding properties of PMX1 to serum response factor, Oncogene, 27, 6056, 10.1038/onc.2008.210 Petit, 2010, NUP98-HMGB3: a novel oncogenic fusion, Leukemia, 24, 654, 10.1038/leu.2009.241 Petit, 2012, Functional analysis of the NUP98-CCDC28A fusion protein, Haematologica, 97, 379, 10.3324/haematol.2011.047969 Pan, 2016, Human NUP98-IQCG fusion protein induces acute myelomonocytic leukemia in mice by dysregulating the Hox/Pbx3 pathway, Leukemia, 30, 1590, 10.1038/leu.2015.347 Iwasaki, 2005, Identification of cooperative genes for NUP98-HOXA9 in myeloid leukemogenesis using a mouse model, Blood, 105, 784, 10.1182/blood-2004-04-1508 Lin, 2005, NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia, Blood, 106, 287, 10.1182/blood-2004-12-4794 Saw, 2013, The fusion partner specifies the oncogenic potential of NUP98 fusion proteins, Leuk Res, 37, 1668, 10.1016/j.leukres.2013.09.013 Gough, 2014, NUP98-PHF23 is a chromatin-modifying oncoprotein that causes a wide array of leukemias sensitive to inhibition of PHD histone reader function, Cancer Discov, 4, 564, 10.1158/2159-8290.CD-13-0419 Fisher, 2020, Transforming activities of the NUP98-KMT2A fusion gene associated with myelodysplasia and acute myeloid leukemia, Haematologica, 105, 1857, 10.3324/haematol.2019.219188 Chung, 2006, Enforced expression of NUP98-HOXA9 in human CD34(+) cells enhances stem cell proliferation, Cancer Res, 66, 11781, 10.1158/0008-5472.CAN-06-0706 Imren, 2014, Modeling de novo leukemogenesis from human cord blood with MN1 and NUP98HOXD13, Blood, 124, 3608, 10.1182/blood-2014-04-564666 Cardin, 2019, Human models of NUP98-KDM5A megakaryocytic leukemia in mice contribute to uncovering new biomarkers and therapeutic vulnerabilities, Blood Adv, 3, 3307, 10.1182/bloodadvances.2019030981 Thiollier, 2012, Characterization of novel genomic alterations and therapeutic approaches using acute megakaryoblastic leukemia xenograft models, J Exp Med, 209, 2017, 10.1084/jem.20121343 Calvo, 2002, Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1, Oncogene, 21, 4247, 10.1038/sj.onc.1205516 Ghannam, 2004, The oncogene Nup98-HOXA9 induces gene transcription in myeloid cells, J Biol Chem, 279, 866, 10.1074/jbc.M307280200 Schmoellerl, 2020, CDK6 is an essential direct target of NUP98 fusion proteins in acute myeloid leukemia, Blood, 136, 387, 10.1182/blood.2019003267 Boija, 2018, Transcription factors activate genes through the phase-separation capacity of their activation domains, Cell, 175, 1842, 10.1016/j.cell.2018.10.042 Schmidt, 2015, Nup98 FG domains from diverse species spontaneously phase-separate into particles with nuclear pore-like permselectivity, eLife, 4, 4, 10.7554/eLife.04251 Kasper, 1999, CREB binding protein interacts with nucleoporin-specific FG repeats that activate transcription and mediate NUP98-HOXA9 oncogenicity, Mol Cell Biol, 19, 764, 10.1128/MCB.19.1.764 Fahrenkrog, 2016, Expression of leukemia-associated Nup98 fusion proteins generates an aberrant nuclear envelope phenotype, PLoS One, 11, e0152321, 10.1371/journal.pone.0152321 Cheng, 2017, Loss of p300 accelerates MDS-associated leukemogenesis, Leukemia, 31, 1382, 10.1038/leu.2016.347 Rio-Machin, 2017, The molecular pathogenesis of the NUP98-HOXA9 fusion protein in acute myeloid leukemia, Leukemia, 31, 2000, 10.1038/leu.2017.194 Yung, 2011, Delineating domains and functions of NUP98 contributing to the leukemogenic activity of NUP98-HOX fusions, Leuk Res, 35, 545, 10.1016/j.leukres.2010.10.006 Pineault, 2005, Transplantable cell lines generated with NUP98-Hox fusion genes undergo leukemic progression by Meis1 independent of its binding to DNA, Leukemia, 19, 636, 10.1038/sj.leu.2403696 Argiropoulos, 2008, Linkage of Meis1 leukemogenic activity to multiple downstream effectors including Trib2 and Ccl3, Exp Hematol, 36, 845, 10.1016/j.exphem.2008.02.011 Lai, 2017, Meis2 as a critical player in MN1-induced leukemia, Blood Cancer J, 7, e613, 10.1038/bcj.2017.86 Vegi, 2016, MEIS2 is an oncogenic partner in AML1-ETO-positive AML, Cell Rep, 16, 498, 10.1016/j.celrep.2016.05.094 Franks, 2017, Nup98 recruits the Wdr82-Set1A/COMPASS complex to promoters to regulate H3K4 trimethylation in hematopoietic progenitor cells, Genes Dev, 31, 2222, 10.1101/gad.306753.117 Xu, 2016, NUP98 fusion proteins interact with the NSL and MLL1 complexes to drive leukemogenesis, Cancer Cell, 30, 863, 10.1016/j.ccell.2016.10.019 Valerio, 2017, Histone acetyltransferase activity of MOF is required for MLL-AF9 leukemogenesis, Cancer Res, 77, 1753, 10.1158/0008-5472.CAN-16-2374 Takeda, 2010, Inhibition of CRM1-mediated nuclear export of transcription factors by leukemogenic NUP98 fusion proteins, J Biol Chem, 285, 16248, 10.1074/jbc.M109.048785 Oka, 2016, Chromatin-prebound Crm1 recruits Nup98-HoxA9 fusion to induce aberrant expression of Hox cluster genes, eLife, 5, e09540, 10.7554/eLife.09540 Salsi, 2016, NUP98 fusion oncoproteins interact with the APC/C(Cdc20) as a pseudosubstrate and prevent mitotic checkpoint complex binding, Cell Cycle, 15, 2275, 10.1080/15384101.2016.1172156 Salsi, 2014, NUP98 fusion oncoproteins promote aneuploidy by attenuating the mitotic spindle checkpoint, Cancer Res, 74, 1079, 10.1158/0008-5472.CAN-13-0912 Puthiyaveetil, 2013, Non-homologous end joining mediated DNA repair is impaired in the NUP98-HOXD13 mouse model for myelodysplastic syndrome, Leuk Res, 37, 112, 10.1016/j.leukres.2012.10.012 Slape, 2012, Inhibition of apoptosis by BCL2 prevents leukemic transformation of a murine myelodysplastic syndrome, Blood, 120, 2475, 10.1182/blood-2012-05-430736 Guirguis, 2016, PUMA promotes apoptosis of hematopoietic progenitors driving leukemic progression in a mouse model of myelodysplasia, Cell Death Differ, 23, 1049, 10.1038/cdd.2015.159 Humeniuk, 2014, Brief report: Loss of p15Ink4b accelerates development of myeloid neoplasms in Nup98-HoxD13 transgenic mice, Stem Cells, 32, 1361, 10.1002/stem.1635 Grove, 2014, Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer?, Dis Model Mech, 7, 941, 10.1242/dmm.015974 Abdul-Nabi, 2010, In vitro transformation of primary human CD34+ cells by AML fusion oncogenes: early gene expression profiling reveals possible drug target in AML, PLoS One, 5, e12464, 10.1371/journal.pone.0012464 Thanasopoulou, 2014, Potent co-operation between the NUP98-NSD1 fusion and the FLT3-ITD mutation in acute myeloid leukemia induction, Haematologica, 99, 1465, 10.3324/haematol.2013.100917 Greenblatt, 2012, Knock-in of a FLT3/ITD mutation cooperates with a NUP98-HOXD13 fusion to generate acute myeloid leukemia in a mouse model, Blood, 119, 2883, 10.1182/blood-2011-10-382283 Shima, 2017, MLL is essential for NUP98-HOXA9-induced leukemia, Leukemia, 31, 2200, 10.1038/leu.2017.62 Akiki, 2013, NUP98-NSD1 fusion in association with FLT3-ITD mutation identifies a prognostically relevant subgroup of pediatric acute myeloid leukemia patients suitable for monitoring by real time quantitative PCR, Genes Chromosomes Cancer, 52, 1053, 10.1002/gcc.22100 Dash, 2002, A murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9, Proc Natl Acad Sci USA, 99, 7622, 10.1073/pnas.102583199 Crescenzi, 2015, NUP98/11p15 translocations affect CD34+ cells in myeloid and T lymphoid leukemias, Leuk Res, 39, 769, 10.1016/j.leukres.2015.04.014 Lin, 2006, Notch1 mutations are important for leukemic transformation in murine models of precursor-T leukemia/lymphoma, Blood, 107, 2540, 10.1182/blood-2005-07-3013 Lopez, 2017, Pediatric acute megakaryoblastic leukemia: multitasking fusion proteins and oncogenic cooperations, Trends Cancer, 3, 631, 10.1016/j.trecan.2017.07.003 Benevolenskaya, 2005, Binding of pRB to the PHD protein RBP2 promotes cellular differentiation, Mol Cell, 18, 623, 10.1016/j.molcel.2005.05.012 Lin, 2011, Loss of the retinoblastoma binding protein 2 (RBP2) histone demethylase suppresses tumorigenesis in mice lacking Rb1 or Men1, Proc Natl Acad Sci USA, 108, 13379, 10.1073/pnas.1110104108 Defeo-Jones, 1991, Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product, Nature, 352, 251, 10.1038/352251a0 Taketani, 2010, High frequencies of simultaneous FLT3-ITD, WT1 and KIT mutations in hematological malignancies with NUP98-fusion genes, Leukemia, 24, 1975, 10.1038/leu.2010.207 Yang, 2017, Chromosome t(7;11)(p15;p15) translocation in acute myeloid leukemia coexisting with multilineage dyspoiesis and mutations in NRAS and WT1: A case report and literature review, Oncol Lett, 13, 3066, 10.3892/ol.2017.5823 Lavallée, 2016, Identification of MYC mutations in acute myeloid leukemias with NUP98-NSD1 translocations, Leukemia, 30, 1621, 10.1038/leu.2016.19 Dong, 2019, Synergy of NUP98-HOXA10 fusion gene and NrasG12D mutation preserves the stemness of hematopoietic stem cells on culture condition, Cells, 8, E951, 10.3390/cells8090951 Slape, 2008, Leukemic transformation in mice expressing a NUP98-HOXD13 transgene is accompanied by spontaneous mutations in Nras, Kras, and Cbl, Blood, 112, 2017, 10.1182/blood-2008-01-135186 Terui, 2003, Successful treatment of acute myelomonocytic leukaemia with NUP98-HOXD11 fusion transcripts and monitoring of minimal residual disease, Br J Haematol, 120, 274, 10.1046/j.1365-2141.2003.04052.x Yamamoto, 2012, Expression of the novel NUP98/PSIP1 fusion transcripts in myelodysplastic syndrome with t(9;11)(p22;p15), Eur J Haematol, 88, 244, 10.1111/j.1600-0609.2011.01736.x Au, 2019, Rapid detection of chromosomal translocation and precise breakpoint characterization in acute myeloid leukemia by nanopore long-read sequencing, Cancer Genet, 239, 22, 10.1016/j.cancergen.2019.08.005 Chari, 2019, Oral selinexor-dexamethasone for triple-class refractory multiple myeloma, N Engl J Med, 381, 727, 10.1056/NEJMoa1903455 Alexander, 2016, Phase I study of selinexor, a selective inhibitor of nuclear export, in combination with fludarabine and cytarabine, in pediatric relapsed or refractory acute leukemia, J Clin Oncol, 34, 4094, 10.1200/JCO.2016.67.5066 Wang, 2019, The past, present, and future of CRM1/XPO1 inhibitors, Stem Cell Investig, 6, 6, 10.21037/sci.2019.02.03 Giotopoulos, 2016, The epigenetic regulators CBP and p300 facilitate leukemogenesis and represent therapeutic targets in acute myeloid leukemia, Oncogene, 35, 279, 10.1038/onc.2015.92 Deshpande, 2014, AF10 regulates progressive H3K79 methylation and HOX gene expression in diverse AML subtypes, Cancer Cell, 26, 896, 10.1016/j.ccell.2014.10.009 Krivtsov, 2019, A menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia, Cancer Cell, 36, 660, 10.1016/j.ccell.2019.11.001 Stein, 2018, The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia, Blood, 131, 2661, 10.1182/blood-2017-12-818948 Man, 2018, p300 suppresses leukemia development in NUP98-HOXD13 driven myelodysplastic syndrome, Oncotarget, 9, 26603, 10.18632/oncotarget.23402 Gale, 2016, Screen-identified selective inhibitor of lysine demethylase 5A blocks cancer cell growth and drug resistance, Oncotarget, 7, 39931, 10.18632/oncotarget.9539 Hinohara, 2018, KDM5 histone demethylase activity links cellular transcriptomic heterogeneity to therapeutic resistance [published correction appears in Cancer Cell. 2019;35(2):330-332], Cancer Cell, 34, 939, 10.1016/j.ccell.2018.10.014 Stone, 2017, Midostaurin plus chemotherapy for acute myeloid leukemia with a FLT3 mutation, N Engl J Med, 377, 454, 10.1056/NEJMoa1614359 Perl, 2019, Gilteritinib or chemotherapy for relapsed or refractory FLT3-mutated AML, N Engl J Med, 381, 1728, 10.1056/NEJMoa1902688 Kivioja, 2019, Dasatinib and navitoclax act synergistically to target NUP98-NSD1+/FLT3-ITD+ acute myeloid leukemia, Leukemia, 33, 1360, 10.1038/s41375-018-0327-2 Ofran, 2014, Concealed dagger in FLT3/ITD+ AML, Blood, 124, 2317, 10.1182/blood-2014-09-597690 Yin, 2019, Engineered Bcor mutations lead to acute leukemia of progenitor B-1 lymphocyte origin in a sensitized background, Blood, 133, 2610, 10.1182/blood.2018864173 Lahortiga, 2003, NUP98 is fused to adducin 3 in a patient with T-cell acute lymphoblastic leukemia and myeloid markers, with a new translocation t(10;11)(q25;p15), Cancer Res, 63, 3079 Ishikawa, 2007, A novel gene, ANKRD28 on 3p25, is fused with NUP98 on 11p15 in a cryptic 3-way translocation of t(3;5;11)(p25;q35;p15) in an adult patient with myelodysplastic syndrome/acute myelogenous leukemia, Int J Hematol, 86, 238, 10.1007/BF03006927 Tosi, 2005, Characterization of 6q abnormalities in childhood acute myeloid leukemia and identification of a novel t(6;11)(q24.1;p15.5) resulting in a NUP98-C6orf80 fusion in a case of acute megakaryoblastic leukemia, Genes Chromosomes Cancer, 44, 225, 10.1002/gcc.20233 Panagopoulos, 2003, Fusion of the NUP98 gene and the homeobox gene HOXC13 in acute myeloid leukemia with t(11;12)(p15;q13), Genes Chromosomes Cancer, 36, 107, 10.1002/gcc.10139 Gorello, 2008, t(3;11)(q12;p15)/NUP98-LOC348801 fusion transcript in acute myeloid leukemia, Haematologica, 93, 1398, 10.3324/haematol.12945 Zhu, 2020, Identification of a novel NUP98-RARA fusion transcript as the 14th variant of acute promyelocytic leukemia, Am J Hematol, 95, E184, 10.1002/ajh.25807 Such, 2011, A novel NUP98/RARG gene fusion in acute myeloid leukemia resembling acute promyelocytic leukemia, Blood, 117, 242, 10.1182/blood-2010-06-291658 Ahuja, 1999, The t(11;20)(p15;q11) chromosomal translocation associated with therapy-related myelodysplastic syndrome results in an NUP98-TOP1 fusion, Blood, 94, 3258, 10.1182/blood.V94.9.3258 Nebral, 2005, NUP98 is fused to topoisomerase (DNA) IIbeta 180 kDa (TOP2B) in a patient with acute myeloid leukemia with a new t(3;11)(p24;p15), Clin Cancer Res, 11, 6489, 10.1158/1078-0432.CCR-05-0150 Chen, 2018, Identification of fusion genes and characterization of transcriptome features in T-cell acute lymphoblastic leukemia, Proc Natl Acad Sci USA, 115, 373, 10.1073/pnas.1717125115 St. Jude Children’s Research Hospital . PROPEL: public resource of patient-derived and expanded leukemias.www.stjude.org/PROPEL. Accessed 20 August 2020. Gallego Hernanz, 2019, Long-term molecular remission in a patient with acute myeloid leukemia harboring a new NUP98-LEDGF rearrangement, Cancer Med, 8, 1765, 10.1002/cam4.2051 Luo, 2019, A novel entity of acute myeloid leukaemia with recurrent RARG-rearrangement resembling acute promyelocytic leukaemia, Leuk Res, 77, 14, 10.1016/j.leukres.2018.12.009 Yamamoto, 2005, Clonal evolution with inv(11)(p15q22) and NUP98/DDX10 fusion gene in imatinib-resistant chronic myelogenous leukemia, Cancer Genet Cytogenet, 157, 104, 10.1016/j.cancergencyto.2004.06.014 Cui, 2016, A unique acute myeloid leukemia patient with cryptic NUP98-NSD1 gene and ASXL1 mutation, Leuk Lymphoma, 57, 196, 10.3109/10428194.2015.1037755 Mecucci, 2000, t(4;11)(q21;p15) translocation involving NUP98 and RAP1GDS1 genes: characterization of a new subset of T acute lymphoblastic leukaemia, Br J Haematol, 109, 788, 10.1046/j.1365-2141.2000.02106.x